Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core US Aggregate Bond ETF
AGG
|
+$956M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$924M |
| 3 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$769M |
| 4 |
Vanguard Morningstar Value ETF
VTV
|
+$410M |
| 5 |
Kenvue
KVUE
|
+$393M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-5 Year TIPS Bond ETF
STIP
|
+$411M |
| 2 |
Johnson & Johnson
JNJ
|
+$234M |
| 3 |
Cisco
CSCO
|
+$181M |
| 4 |
iShares Gold Trust
IAU
|
+$143M |
| 5 |
LSI
Life Storage, Inc.
LSI
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.03% |
| 2 | Healthcare | 12.31% |
| 3 | Financials | 11.79% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Industrials | 9.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3351
Envela
ELA
$563M
| $101K | ﹤0.01% |
21,390
| – | – |
|
|
EGIO
3352
DELISTED
Edgio, Inc. Common Stock
EGIO
| $99.8K | ﹤0.01% |
+2,928
| New | +$91.7K |
|
3353
Dragonfly Energy
DFLI
$15M
| $99.6K | ﹤0.01% |
719
-173
| -19% | -$30.4K |
|
3354
OppFi
OPFI
$800M
| $99.3K | ﹤0.01% |
39,409
+9,988
| +34% | +$23.2K |
|
3355
Beneficient
BENF
$46.4M
| $98K | ﹤0.01% |
+59
| New | +$92.6K |
|
|
UHG
3356
DELISTED
United Homes Group
UHG
| $97.4K | ﹤0.01% |
17,396
-22,984
| -57% | -$204K |
|
3357
Nkarta
NKTX
$150M
| $96.1K | ﹤0.01% |
69,109
-173,728
| -72% | -$330K |
|
3358
American Public Education
APEI
$890M
| $95.5K | ﹤0.01% |
+19,174
| New | +$98.2K |
|
3359
Adicet Bio
ACET
$85.2M
| $95.2K | ﹤0.01% |
4,341
-828
| -16% | -$29.2K |
|
|
RBOT
3360
DELISTED
Vicarious Surgical
RBOT
| $94.6K | ﹤0.01% |
5,339
-6,914
| -56% | -$252K |
|
3361
iShares Select Dividend ETF
DVY
$23.5B
| $93.3K | ﹤0.01% |
171,206
+121,551
| +245% | +$13.8M |
|
|
GATO
3362
DELISTED
Gatos Silver, Inc.
GATO
| $92.7K | ﹤0.01% |
17,898
| – | – |
|
3363
The RealReal
REAL
$1.46B
| $92.4K | ﹤0.01% |
43,796
| – | – |
|
3364
Akebia Therapeutics
AKBA
$354M
| $91K | ﹤0.01% |
79,804
| – | – |
|
3365
Standard BioTools
LAB
$340M
| $90.5K | ﹤0.01% |
31,192
| – | – |
|
|
RENT
3366
Rent the Runway
RENT
$121M
| $89.8K | ﹤0.01% |
6,600
-10,665
| -62% | -$304K |
|
3367
Orion Group Holdings
ORN
$396M
| $89.4K | ﹤0.01% |
16,674
| – | – |
|
3368
Bionano Genomics
BNGO
$12.3M
| $84.8K | ﹤0.01% |
467
-1,699
| -78% | -$445K |
|
|
MMAT
3369
DELISTED
Meta Materials Inc. Common Stock
MMAT
| $83.5K | ﹤0.01% |
+3,939
| New | +$86.2K |
|
3370
Redwire
RDW
$2.06B
| $81.6K | ﹤0.01% |
28,228
| – | – |
|
3371
Grove Collaborative
GROV
$46.2M
| $81.2K | ﹤0.01% |
+30,520
| New | +$77.4K |
|
3372
Lifecore Biomedical
LFCR
$166M
| $78.7K | ﹤0.01% |
10,427
| – | – |
|
3373
Outlook Therapeutics
OTLK
$183M
| $78.4K | ﹤0.01% |
17,731
-3,125
| -15% | -$69.1K |
|
3374
Surf Air Mobility
SRFM
$84.9M
| $78.3K | ﹤0.01% |
+6,860
| New | +$81.5K |
|
3375
Ardagh Metal Packaging
AMBP
$2.83B
| $77.3K | ﹤0.01% |
24,684
+1,628
| +7% | +$5.72K |
|
Similar funds
Charles Schwab's Q3 2023 Portfolio in Review
As of Q3 2023, Charles Schwab held 3,713 positions worth $349B, down 0.3% from $350B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Charles Schwab deployed $12.6B of net new capital in Q3 2023, opening 104 new positions and adding to 2,394 existing holdings. Its largest new stake was Vanguard Morningstar Value ETF: 2,862,740 shares worth $395M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $234M trimmed.
- Charles Schwab's largest Q3 2023 buy was Vanguard Morningstar Value ETF: 2,862,740 shares worth $395M.
- Charles Schwab added most to iShares Core US Aggregate Bond ETF in Q3 2023, an estimated $956M increase.
- Charles Schwab's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $234M.
- Charles Schwab fully exited iShares 0-5 Year TIPS Bond ETF in Q3 2023, selling an estimated $411M.
- Charles Schwab's ten largest holdings make up 18% of its $349B portfolio in Q3 2023.
- Charles Schwab opened 104 new positions and closed 137 in Q3 2023.
- Charles Schwab's portfolio value fell 0.3% quarter-over-quarter to $349B.
Based on Charles Schwab's 13F filing for Q3 2023, filed 8 Nov 2023.